SEC Form 4 · accession 0001209191-19-001491
IRONWOOD PHARMACEUTICALS INC · IRWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marsha Fanucci
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 3, 2019 · 7:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001446847
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1 | Dec 31, 2018 | J | 44,863 | — | D | 0 | D | |
| Class A Common StockF1 | Dec 31, 2018 | J | 44,863 | — | A | 136,719 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 31, 2018, each share of the Issuer's outstanding Class B Common Stock automatically converted into one share of the Issuer's Class A Common Stock pursuant to the Issuer's certificate of incorporation.